A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients

• Үндсэн зохиолчид: Riccardo Giossi (Зохиогч), Danilo Menichelli (Зохиогч), Arianna Pani (Зохиогч), Elena Tratta (Зохиогч), Alessandra Romandini (Зохиогч), Rossana Roncato (Зохиогч), Alessandro Nani (Зохиогч), Paolo Schenardi (Зохиогч), Erika Diani (Зохиогч), Veronica Andrea Fittipaldo (Зохиогч), Alessio Farcomeni (Зохиогч), Francesco Scaglione (Зохиогч), Daniele Pastori (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2021-09-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Background: Antithrombotic treatment, including low molecular weight heparin (LMWH) or unfractionated heparin (UFH), has been proposed as a potential therapy for coronavirus disease 2019 (COVID-19) to lower diffuse intravascular clotting activation. However, it is unclear whether prophylactic or the...